Thomas Parks
Hoofd Techniek/Wetenschap/O&O bij University of Utah Research Foundation
Profiel
Thomas N.
Parks was the founder of NPS Pharmaceuticals, Inc. founded in 1986, where he held the title of Director from 1986 to 2006.
Currently, he holds multiple positions including Independent Director at Q Therapeutics, Inc. since 2017, Director at SentrX Animal Care, Inc., Director at Navigen, Inc., and Vice President-Research at University of Utah Research Foundation.
Dr. Parks received a doctorate degree from Yale University and an undergraduate degree from the University of California, Irvine.
Actieve functies van Thomas Parks
Bedrijven | Functie | Begin |
---|---|---|
University of Utah Research Foundation
University of Utah Research Foundation Miscellaneous Commercial ServicesCommercial Services The University of Utah Research Foundation promotes, conducts and facilitates research, development and dissemination, and application of knowledge in the fields of science, technology, medicine, business, education and engineering. The foundation's headquarters is located in Salt Lake City, UT. | Hoofd Techniek/Wetenschap/O&O | 13-06-2011 |
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Directeur/Bestuurslid | 07-08-2017 |
SentrX Animal Care, Inc.
SentrX Animal Care, Inc. Pharmaceuticals: MajorHealth Technology SentrX Animal Care, Inc. provides veterinary care services for animals. Its products include gels, film and field treatment kits, film-on-gauzes, adhesion prevention films, spray bottles, and corneal repair gel drops. The company’s products are used for horses, cats and dogs. The company was founded by Richard K. Koehn and Glenn D. Prestwich in 2006 and is headquartered in Salt Lake City, UT. | Directeur/Bestuurslid | - |
Navigen, Inc.
Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Thomas Parks
Bedrijven | Functie | Einde |
---|---|---|
NPS PHARMACEUTICALS, INC. | Oprichter | 01-05-2006 |
Opleiding van Thomas Parks
Yale University | Doctorate Degree |
University of California, Irvine | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
University of Utah Research Foundation
University of Utah Research Foundation Miscellaneous Commercial ServicesCommercial Services The University of Utah Research Foundation promotes, conducts and facilitates research, development and dissemination, and application of knowledge in the fields of science, technology, medicine, business, education and engineering. The foundation's headquarters is located in Salt Lake City, UT. | Commercial Services |
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Health Technology |
SentrX Animal Care, Inc.
SentrX Animal Care, Inc. Pharmaceuticals: MajorHealth Technology SentrX Animal Care, Inc. provides veterinary care services for animals. Its products include gels, film and field treatment kits, film-on-gauzes, adhesion prevention films, spray bottles, and corneal repair gel drops. The company’s products are used for horses, cats and dogs. The company was founded by Richard K. Koehn and Glenn D. Prestwich in 2006 and is headquartered in Salt Lake City, UT. | Health Technology |
Navigen, Inc.
Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Health Technology |